Patient experiences with influenza immunizations administered by pharmacists.
Identifieur interne : 000062 ( Main/Corpus ); précédent : 000061; suivant : 000063Patient experiences with influenza immunizations administered by pharmacists.
Auteurs : Jennifer E. Isenor ; Amy C. Wagg ; Susan K. BowlesSource :
- Human vaccines & immunotherapeutics [ 2164-554X ] ; 2018.
English descriptors
- KwdEn :
- Humans, Immunization Programs (methods), Immunization Programs (statistics & numerical data), Influenza Vaccines (administration & dosage), Influenza Vaccines (immunology), Influenza, Human (immunology), Influenza, Human (prevention & control), Nova Scotia, Pharmacies (statistics & numerical data), Pharmacists (statistics & numerical data), Vaccination (statistics & numerical data).
- MESH :
- chemical , administration & dosage : Influenza Vaccines.
- chemical , immunology : Influenza Vaccines.
- geographic : Nova Scotia.
- immunology : Influenza, Human.
- methods : Immunization Programs.
- prevention & control : Influenza, Human.
- statistics & numerical data : Immunization Programs, Pharmacies, Pharmacists, Vaccination.
- Humans.
Abstract
Influenza vaccination is the most effective way to reduce influenza infection and related complications. Unfortunately, vaccination coverage remains suboptimal. The addition of pharmacists as immunizers may assist in improving vaccine coverage. The experiences of patients who have received influenza vaccines from pharmacists is an important consideration for jurisdictions considering the addition of pharmacists as immunizers. We describe the reported experiences of recipients of influenza vaccinations by pharmacists in the community pharmacy setting in Nova Scotia, Canada. During the 2013-2014 influenza season, a paper-based quality assurance questionnaire was provided to interested vaccine recipients to assess their previous vaccination experiences and current experience at the pharmacy. More than 6,500 vaccine recipients completed questionnaires. The majority of respondents cited convenience as a main reason for receiving the vaccine in the pharmacy, with 50% indicating the service was better in the pharmacy and another 40% that the service was as good as elsewhere. Respondents also reported a positive environment in the pharmacy (e.g., less stressful, less exposure to sick people) as well as professionalism and knowledge of the pharmacists. Areas for improvement identified included better communication around the paperwork required (e.g., consent forms) and the wait time post-vaccination. This evaluation demonstrated that people who chose to be vaccinated by community pharmacists reported positive experiences and convenience was the primary factor for selecting a pharmacy as the site for vaccination.
DOI: 10.1080/21645515.2018.1423930
PubMed: 29303681
Links to Exploration step
pubmed:29303681Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Patient experiences with influenza immunizations administered by pharmacists.</title><author><name sortKey="Isenor, Jennifer E" sort="Isenor, Jennifer E" uniqKey="Isenor J" first="Jennifer E" last="Isenor">Jennifer E. Isenor</name><affiliation><nlm:affiliation>a College of Pharmacy, Faculty of Health and Faculty of Medicine, Dalhousie University, Canadian Center for Vaccinology , Dalhousie University, IWK Health Centre, and Nova Scotia Health Authority, Dalhousie University , Halifax , Nova Scotia , Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Wagg, Amy C" sort="Wagg, Amy C" uniqKey="Wagg A" first="Amy C" last="Wagg">Amy C. Wagg</name><affiliation><nlm:affiliation>b Pharmacy Association of Nova Scotia , Dartmouth , Nova Scotia , Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Bowles, Susan K" sort="Bowles, Susan K" uniqKey="Bowles S" first="Susan K" last="Bowles">Susan K. Bowles</name><affiliation><nlm:affiliation>c Department of Pharmacy, Nova Scotia Health Authority-Central Zone, Halifax, Nova Scotia, College of Pharmacy, Faculty of Health and Faculty Medicine, Dalhousie University, Canadian Centre for Vaccinology , Dalhousie University, IWK Health Centre and Nova Scotia Health Authority , Halifax , Nova Scotia.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2018">2018</date><idno type="RBID">pubmed:29303681</idno><idno type="pmid">29303681</idno><idno type="doi">10.1080/21645515.2018.1423930</idno><idno type="wicri:Area/Main/Corpus">000062</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000062</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Patient experiences with influenza immunizations administered by pharmacists.</title><author><name sortKey="Isenor, Jennifer E" sort="Isenor, Jennifer E" uniqKey="Isenor J" first="Jennifer E" last="Isenor">Jennifer E. Isenor</name><affiliation><nlm:affiliation>a College of Pharmacy, Faculty of Health and Faculty of Medicine, Dalhousie University, Canadian Center for Vaccinology , Dalhousie University, IWK Health Centre, and Nova Scotia Health Authority, Dalhousie University , Halifax , Nova Scotia , Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Wagg, Amy C" sort="Wagg, Amy C" uniqKey="Wagg A" first="Amy C" last="Wagg">Amy C. Wagg</name><affiliation><nlm:affiliation>b Pharmacy Association of Nova Scotia , Dartmouth , Nova Scotia , Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Bowles, Susan K" sort="Bowles, Susan K" uniqKey="Bowles S" first="Susan K" last="Bowles">Susan K. Bowles</name><affiliation><nlm:affiliation>c Department of Pharmacy, Nova Scotia Health Authority-Central Zone, Halifax, Nova Scotia, College of Pharmacy, Faculty of Health and Faculty Medicine, Dalhousie University, Canadian Centre for Vaccinology , Dalhousie University, IWK Health Centre and Nova Scotia Health Authority , Halifax , Nova Scotia.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Human vaccines & immunotherapeutics</title><idno type="eISSN">2164-554X</idno><imprint><date when="2018" type="published">2018</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Humans</term><term>Immunization Programs (methods)</term><term>Immunization Programs (statistics & numerical data)</term><term>Influenza Vaccines (administration & dosage)</term><term>Influenza Vaccines (immunology)</term><term>Influenza, Human (immunology)</term><term>Influenza, Human (prevention & control)</term><term>Nova Scotia</term><term>Pharmacies (statistics & numerical data)</term><term>Pharmacists (statistics & numerical data)</term><term>Vaccination (statistics & numerical data)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Nova Scotia</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Immunization Programs</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Immunization Programs</term><term>Pharmacies</term><term>Pharmacists</term><term>Vaccination</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Influenza vaccination is the most effective way to reduce influenza infection and related complications. Unfortunately, vaccination coverage remains suboptimal. The addition of pharmacists as immunizers may assist in improving vaccine coverage. The experiences of patients who have received influenza vaccines from pharmacists is an important consideration for jurisdictions considering the addition of pharmacists as immunizers. We describe the reported experiences of recipients of influenza vaccinations by pharmacists in the community pharmacy setting in Nova Scotia, Canada. During the 2013-2014 influenza season, a paper-based quality assurance questionnaire was provided to interested vaccine recipients to assess their previous vaccination experiences and current experience at the pharmacy. More than 6,500 vaccine recipients completed questionnaires. The majority of respondents cited convenience as a main reason for receiving the vaccine in the pharmacy, with 50% indicating the service was better in the pharmacy and another 40% that the service was as good as elsewhere. Respondents also reported a positive environment in the pharmacy (e.g., less stressful, less exposure to sick people) as well as professionalism and knowledge of the pharmacists. Areas for improvement identified included better communication around the paperwork required (e.g., consent forms) and the wait time post-vaccination. This evaluation demonstrated that people who chose to be vaccinated by community pharmacists reported positive experiences and convenience was the primary factor for selecting a pharmacy as the site for vaccination.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29303681</PMID><DateCompleted><Year>2019</Year><Month>01</Month><Day>02</Day></DateCompleted><DateRevised><Year>2019</Year><Month>01</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2164-554X</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>03</Month><Day>04</Day></PubDate></JournalIssue><Title>Human vaccines & immunotherapeutics</Title><ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation></Journal><ArticleTitle>Patient experiences with influenza immunizations administered by pharmacists.</ArticleTitle><Pagination><MedlinePgn>706-711</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/21645515.2018.1423930</ELocationID><Abstract><AbstractText>Influenza vaccination is the most effective way to reduce influenza infection and related complications. Unfortunately, vaccination coverage remains suboptimal. The addition of pharmacists as immunizers may assist in improving vaccine coverage. The experiences of patients who have received influenza vaccines from pharmacists is an important consideration for jurisdictions considering the addition of pharmacists as immunizers. We describe the reported experiences of recipients of influenza vaccinations by pharmacists in the community pharmacy setting in Nova Scotia, Canada. During the 2013-2014 influenza season, a paper-based quality assurance questionnaire was provided to interested vaccine recipients to assess their previous vaccination experiences and current experience at the pharmacy. More than 6,500 vaccine recipients completed questionnaires. The majority of respondents cited convenience as a main reason for receiving the vaccine in the pharmacy, with 50% indicating the service was better in the pharmacy and another 40% that the service was as good as elsewhere. Respondents also reported a positive environment in the pharmacy (e.g., less stressful, less exposure to sick people) as well as professionalism and knowledge of the pharmacists. Areas for improvement identified included better communication around the paperwork required (e.g., consent forms) and the wait time post-vaccination. This evaluation demonstrated that people who chose to be vaccinated by community pharmacists reported positive experiences and convenience was the primary factor for selecting a pharmacy as the site for vaccination.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Isenor</LastName><ForeName>Jennifer E</ForeName><Initials>JE</Initials><Identifier Source="ORCID">0000-0003-1648-7362</Identifier><AffiliationInfo><Affiliation>a College of Pharmacy, Faculty of Health and Faculty of Medicine, Dalhousie University, Canadian Center for Vaccinology , Dalhousie University, IWK Health Centre, and Nova Scotia Health Authority, Dalhousie University , Halifax , Nova Scotia , Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wagg</LastName><ForeName>Amy C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>b Pharmacy Association of Nova Scotia , Dartmouth , Nova Scotia , Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bowles</LastName><ForeName>Susan K</ForeName><Initials>SK</Initials><Identifier Source="ORCID">0000-0003-0821-3222</Identifier><AffiliationInfo><Affiliation>c Department of Pharmacy, Nova Scotia Health Authority-Central Zone, Halifax, Nova Scotia, College of Pharmacy, Faculty of Health and Faculty Medicine, Dalhousie University, Canadian Centre for Vaccinology , Dalhousie University, IWK Health Centre and Nova Scotia Health Authority , Halifax , Nova Scotia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Hum Vaccin Immunother</MedlineTA><NlmUniqueID>101572652</NlmUniqueID><ISSNLinking>2164-5515</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017589" MajorTopicYN="N">Immunization Programs</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009674" MajorTopicYN="N" Type="Geographic">Nova Scotia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010594" MajorTopicYN="N">Pharmacies</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010595" MajorTopicYN="N">Pharmacists</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Canada</Keyword><Keyword MajorTopicYN="Y">immunization</Keyword><Keyword MajorTopicYN="Y">influenza vaccination</Keyword><Keyword MajorTopicYN="Y">pharmaceutical services</Keyword><Keyword MajorTopicYN="Y">pharmacist</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>1</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29303681</ArticleId><ArticleId IdType="doi">10.1080/21645515.2018.1423930</ArticleId><ArticleId IdType="pmc">PMC5861777</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Can Pharm J (Ott). 2013 Jul;146(4):227-32</Citation><ArticleIdList><ArticleId IdType="pubmed">23940480</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2015 Aug 14;33(34):4161-4</Citation><ArticleIdList><ArticleId IdType="pubmed">25896383</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Pharm Assoc (2003). 2010 Mar-Apr 1;50(2):174-80</Citation><ArticleIdList><ArticleId IdType="pubmed">20199959</ArticleId></ArticleIdList></Reference><Reference><Citation>Can Pharm J (Ott). 2013 Jan;146(1):39-46</Citation><ArticleIdList><ArticleId IdType="pubmed">23795168</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Pharm Assoc (2003). 2006 Mar-Apr;46(2):168-79; quiz 179-82</Citation><ArticleIdList><ArticleId IdType="pubmed">16602227</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ Open. 2016 Sep 20;6(9):e011948</Citation><ArticleIdList><ArticleId IdType="pubmed">27650763</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect. 2009 Jun;58(6):446-58</Citation><ArticleIdList><ArticleId IdType="pubmed">19446340</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Vaccin Immunother. 2016 May 3;12 (5):1225-8</Citation><ArticleIdList><ArticleId IdType="pubmed">26863888</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Care. 2001 Apr;39(4):340-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11329521</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 2002 Mar;55(3):279-84</Citation><ArticleIdList><ArticleId IdType="pubmed">11864799</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Fam Med. 2013 Sep-Oct;11(5):429-36</Citation><ArticleIdList><ArticleId IdType="pubmed">24019274</ArticleId></ArticleIdList></Reference><Reference><Citation>CMAJ Open. 2016 Aug 19;4(3):E455-E462</Citation><ArticleIdList><ArticleId IdType="pubmed">27975047</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ Open. 2016 Feb 16;6(2):e009739</Citation><ArticleIdList><ArticleId IdType="pubmed">26883237</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2006 May 1;24(18):4024-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16546307</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2013 Jan 2;31(2):279-84</Citation><ArticleIdList><ArticleId IdType="pubmed">23174197</ArticleId></ArticleIdList></Reference><Reference><Citation>Can Pharm J (Ott). 2014 Nov;147(6):359-65</Citation><ArticleIdList><ArticleId IdType="pubmed">25364353</ArticleId></ArticleIdList></Reference><Reference><Citation>J Fam Pract. 2007 Feb;56(2 Suppl Vaccines):S61-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17270112</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Pharm Pract. 2010 Apr;18(2):100-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20441119</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Clin Pharm. 2016 Apr;38(2):218-22</Citation><ArticleIdList><ArticleId IdType="pubmed">26821372</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Pharm Assoc (2003). 2014 May-Jun;54(3):295-301</Citation><ArticleIdList><ArticleId IdType="pubmed">24728511</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Suppl. 2013 Nov 22;62(3):65-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24264492</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med. 2008 Jul;121(7 Suppl 2):S28-35</Citation><ArticleIdList><ArticleId IdType="pubmed">18589065</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pharm Policy Pract. 2016 Oct 19;9:32</Citation><ArticleIdList><ArticleId IdType="pubmed">27777781</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Vaccin Immunother. 2016 Mar 3;12 (3):623-31</Citation><ArticleIdList><ArticleId IdType="pubmed">26810485</ArticleId></ArticleIdList></Reference><Reference><Citation>Influenza Other Respir Viruses. 2013 Sep;7(5):799-808</Citation><ArticleIdList><ArticleId IdType="pubmed">23122189</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeCanadaV3/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000062 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000062 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= GrippeCanadaV3
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:29303681
|texte= Patient experiences with influenza immunizations administered by pharmacists.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:29303681" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a GrippeCanadaV3
| This area was generated with Dilib version V0.6.35. |  |